Wouter W. Van Willigen
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neurological side-effects associated with immune checkpoint inhibitors
Journal: Nederlands tijdschrift voor geneeskunde
Published: January 22, 2025
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Journal: Nature communications
Published: May 09, 2023
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination.
Journal: Oncoimmunology
Published: January 18, 2021
18F-FDG PET/CT of Multiorgan Sarcoid-Like Reaction During Anti-PD-1 Treatment for Melanoma.
Journal: Clinical nuclear medicine
Published: October 05, 2019
ASO Author Reflections: Frequent Relapses Prior to the Start of Adjuvant Therapy in Stage IIIB/C Melanoma.
Journal: Annals of surgical oncology
Published: July 15, 2019
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
Journal: Annals of surgical oncology
Published: December 19, 2018
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 21, 2018
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time.
Journal: Frontiers in immunology
Published: July 20, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026